Umoja Biopharma

Umoja Biopharma is a biotechnology company focused on developing innovative immunotherapies for cancer treatment. They leverage proprietary technologies to reprogram immune cells directly within the patient’s body, aiming to create more effective and accessible cancer therapies. The company generates revenue through partnerships, licensing agreements, and potential future sales of their therapeutic products. Founded in 2019, Umoja has rapidly advanced its pipeline and secured significant funding, positioning itself as a key player in the field of cell and gene therapy.

Recent Posts by Umoja Biopharma

1-20 of 62